Bookmark

Add to MyYahoo RSS

Harvard Bioscience News

News on Harvard Bioscience (Ticker: HBIO) continually updated from thousands of sources around the net.

17 hrs ago | BayStreet.ca

SeeThruEquity Issues Update on Harvard Bioscience Inc.

New York, NY / ACCESSWIRE / April 17, 2014 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a company update note on Harvard Bioscience Inc. regarding financial and operational results for Q4 2013 and FY 2013.

Comment?

Related Topix: Scientific Instruments, Biotech, Medicine, Healthcare Industry

Tue Apr 15, 2014

Scientific Blogging

Regenerated Esophagus Successfully Transplanted Into Rat

A research team led by Paolo Macchiarini , MD, PhD at Karolinska Institutet in Sweden has successfully transplanted a regenerated esophagus into a rat using a bioreactor developed by Harvard Apparatus Regenerative Technology , a spin-off of Harvard Bioscience.

Comment?

Related Topix: Scientific Instruments, Biotech, Healthcare Industry

Fri Apr 04, 2014

AmericanBankingNews.com

Harvard Bioscience Director David Green Sells 63,501 Shares

Harvard Bioscience Director David Green unloaded 63,501 shares of Harvard Bioscience stock on the open market in a transaction that occurred on Thursday, April 3rd.

Comment?

Related Topix: Scientific Instruments, Biotech, Medicine, Healthcare Industry

Thu Mar 27, 2014

The Motley Fool

I'm Selling Harvard Biosciences

Not bad. But the outlook for the parent company is not as rosy as I had expected, and my expectations were not that high to begin with.

Comment?

Related Topix: Scientific Instruments, Biotech, Medicine, Healthcare Industry

Tue Mar 25, 2014

Seeking Alpha

Ruthigen IPO Set To Soar; Tetraphase To Find Lower Floor

Ruthigen's IPO provides strong investment opportunity based on relative valuations and addressing unmet market need with potential multi-billion dollar market.

Comment?

Related Topix: Tetraphase Pharmaceuticals, Scientific Instruments, Biotech, Medicine, Healthcare Industry

Fri Mar 21, 2014

Sys-Con Media

Harvard Apparatus Regenerative Technology Spotlighted by Fast Company Co.Exist

Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was featured in an article published by Fast Company Co.Exist on March 19. The article, "Lab-Grown Organs Are Out In The Wild, And More Are Coming Soon," recounts the Company's ... (more)

Comment?

Related Topix: Food and Drug Administration, Marketing, Scientific Instruments, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••